International Internet Magazine. Baltic States news & analytics
Sunday, 31.07.2016, 04:37
Lithuania's leading biopharmaceutical manufacturer Sicor Biotech, which is controlled by the international generic drugs producer Teva, posted a net profit of 87.018 mln euros for 2015, more than a two-fold increase from 41.171 mln euros in 2014, reports LETA/BNS.
Keyword tags: Good for Business, Lithuania, Medicine, Technology
European Commission grants EUR 50,000 for commercialization of Latvian-made cancer virotherapy medicine in EU markets19.07.2016
The European Commission has awarded a EUR 50,000 grant to Latvian company Latima for commercialization of a cancer virotherapy medicine in the EU markets, informs LETA.
The Lithuanian parliament on June 28th passed a law on assisted insemination after several years of discussions, opting for a conservative regulation that prohibits freezing of embryos, informs LETA/BNS.
Lithuania's pharmaceutical wholesaler GlaxoSmithKline Lietuva is set to pay out 1.322 million euros as dividends to its sole shareholder after posting a net profit of 1.391 million euros for 2015, informs LETA/BNS.
In addition to CEO of the North Estonia Medical Center (PERH), Tonis Allik, who resigned on June 15 the hospital's board has also limited the powers of PERH's IT director Marko Kilk and catering chief Anu Vahi who also stand suspected of embezzlement, informs LETA/BNS.
The Tallinn city government has initiated a procedure to prepare a detailed plan for the plots at Narva Road 129 and 129b and nearby areas where the city's new main hospital complex is about to be built, informs LETA/BNS.
The Estonian Health Insurance Fund in 2015 covered the medical costs of Estonians in other European Union member states in the amount of 8.5 million euros, informs LETA/BNS.